Allergic Rhinitis

Gergen, 1991, The association of allergen skin test reactivity and respiratory disease among whites in the US population. Data from the Second National Health and Nutrition Examination Survey, 1976 to 1980, Arch Intern Med, 151, 487, 10.1001/archinte.1991.00400030053009

Sibbald, 1991, Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history, Thorax, 46, 895, 10.1136/thx.46.12.895

Sibbald, 1991, Labelling of rhinitis and hayfever by doctors, Thorax, 46, 378, 10.1136/thx.46.5.378

Turkeltaub, 1991, Prevalence of upper and lower respiratory conditions in the US population by social and environmental factors: data from the second National Health and Nutrition Examination Survey, 1976 to 1980 (NHANES II), Ann Allergy, 67, 147

Ng, 1994, Epidemiology of allergic rhinitis and its associated risk factors in Singapore, Int J Epidemiol, 23, 553, 10.1093/ije/23.3.553

Ng, 1994, Epidemiology of chronic (perennial) rhinitis in Singapore: prevalence estimates, demographic variation and clinical allergic presentation, Ann Acad Med Singapore, 23, 83

Droste, 1996, Association of skin test reactivity, specific IgE, total IgE, and eosinophils with nasal symptoms in a community-based population study. The Dutch ECRHS Group, J Allergy Clin Immunol, 97, 922, 10.1016/S0091-6749(96)80066-2

Kerkhof, 1996, Allergy, 51, 770

Sakurai, 1998, Prevalence and risk factors of allergic rhinitis and cedar pollinosis among Japanese men, Prev Med, 27, 617, 10.1006/pmed.1998.0336

Dinmezel, 2005, The prevalence of asthma, allergic rhinitis, and atopy in Antalya, Turkey, Allergy Asthma Proc, 26, 403

Bachert, 2006, Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium, Allergy, 61, 693, 10.1111/j.1398-9995.2006.01054.x

Ray, 1999, Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses, J Allergy Clin Immunol, 103, 401, 10.1016/S0091-6749(99)70463-X

Thompson, 2000, Quality of life in patients with allergic rhinitis, Ann Allergy Asthma Immunol, 85, 338, 10.1016/S1081-1206(10)62543-4

Blaiss, 2007, Allergic rhinoconjunctivitis: burden of disease, Allergy Asthma Proc, 28, 393, 10.2500/aap.2007.28.3013

Lamb, 2006, Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective, Curr Med Res Opin, 22, 1203, 10.1185/030079906X112552

Papadopoulos, 2015, Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report, Allergy, 70, 474, 10.1111/all.12573

Brozek, 2010, Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision, J Allergy Clin Immunol, 126, 466, 10.1016/j.jaci.2010.06.047

Bousquet, 2015, MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation, Allergy, 70, 1372, 10.1111/all.12686

Platts-Mills, 2004, Allergen avoidance, J Allergy Clin Immunol, 113, 388, 10.1016/j.jaci.2003.12.027

Wallace, 2008, The diagnosis and management of rhinitis: an updated practice parameter, J Allergy Clin Immunol, 122, S1, 10.1016/j.jaci.2008.06.003

Rondon, 2014, Follow-up study in local allergic rhinitis shows a consistent entity not evolving to systemic allergic rhinitis, J Allergy Clin Immunol, 133, 1026, 10.1016/j.jaci.2013.10.034

Rondon, 2007, Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis, J Allergy Clin Immunol, 119, 899, 10.1016/j.jaci.2007.01.006

Wheatley, 2015, Clinical practice. Allergic rhinitis, N Engl J Med, 372, 456, 10.1056/NEJMcp1412282

Bousquet, 2008, Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen), Allergy, 63, 8, 10.1111/j.1398-9995.2007.01620.x

Janeway, 2001

Bernstein, 2012, Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States, Postgrad Med, 124, 91, 10.3810/pgm.2012.05.2552

Bielory, 2013, An algorithm for the management of allergic conjunctivitis, Allergy Asthma Proc, 34, 408, 10.2500/aap.2013.34.3695

Di Lorenzo, 2004, Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis, Clin Exp Allergy, 34, 259, 10.1111/j.1365-2222.2004.01877.x

Mygind, 2014, Allergic rhinitis, Chem Immunol Allergy, 100, 62, 10.1159/000358505

Greiner, 2011, Overview of the treatment of allergic rhinitis and nonallergic rhinopathy, Proc Am Thorac Soc, 8, 121, 10.1513/pats.201004-033RN

Bousquet, 2015, Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps, Expert Opin Pharmacother, 16, 913, 10.1517/14656566.2015.1020789

Carr, 2012, A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis, J Allergy Clin Immunol, 129, 1282, 10.1016/j.jaci.2012.01.077

Mygind, 2000, Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy, Allergy, 55, 11, 10.1034/j.1398-9995.2000.00108.x

Ameratunga, 2012, Gluteal subcutaneous atrophy after depot steroid injection for allergic rhinitis, World Allergy Organ J, 5, 168, 10.1097/WOX.0b013e3182758d80

Meltzer, 2010, Treatment of congestion in upper respiratory diseases, Int J Gen Med, 3, 69, 10.2147/IJGM.S8184

Grainger, 2006, Montelukast in allergic rhinitis: a systematic review and meta-analysis, Clin Otolaryngol, 31, 360, 10.1111/j.1749-4486.2006.01276.x

Tzanetos, 2011, Comparison of the sedating effects of levocetirizine and cetirizine: a randomized, double-blind, placebo-controlled trial, Ann Allergy Asthma Immunol, 107, 517, 10.1016/j.anai.2011.08.012

Patel, 2005, Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis, Ann Allergy Asthma Immunol, 95, 551, 10.1016/S1081-1206(10)61018-6

Calderon, 2013, Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report, Allergy, 68, 825, 10.1111/all.12180

Meltzer, 2009, Burden of allergic rhinitis: results from the pediatric allergies in America survey, J Allergy Clin Immunol, 124, S43, 10.1016/j.jaci.2009.05.013

White, 1998, Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?, Clin Exp Allergy, 28, 266, 10.1046/j.1365-2222.1998.00237.x

Calderon, 2007, Allergen injection immunotherapy for seasonal allergic rhinitis, Cochrane Database Syst Rev, 10.1002/14651858.CD001936.pub2

Burks, 2013, Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report, J Allergy Clin Immunol, 131, 1288, 10.1016/j.jaci.2013.01.049

Matricardi, 2011, Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses, J Allergy Clin Immunol, 128, 791, 10.1016/j.jaci.2011.03.049

Cox, 2011, Allergen immunotherapy: a practice parameter third update, J Allergy Clin Immunol, 127, S1, 10.1016/j.jaci.2010.09.034

Durham, 2010, Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet, J Allergy Clin Immunol, 125, 131, 10.1016/j.jaci.2009.10.035

Nelson, 2014, Update on house dust mite immunotherapy: are more studies needed?, Curr Opin Allergy Clin Immunol, 14, 542, 10.1097/ACI.0000000000000104

Epstein, 2013, AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, year 3: what practices modify the risk of systemic reactions?, Ann Allergy Asthma Immunol, 110, 274, 10.1016/j.anai.2013.01.015

Bernstein, 2011, Systemic reactions to subcutaneous allergen immunotherapy, Immunol Allergy Clin N Am, 31, 241, 10.1016/j.iac.2011.02.007

Bernstein, 2004, Immunotherapy Committee AAoAA, Immunology. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001, J Allergy Clin Immunol, 113, 1129, 10.1016/j.jaci.2004.02.006

Maloney, 2014, Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial, Ann Allergy Asthma Immunol, 112, 146, 10.1016/j.anai.2013.11.018

Creticos, 2013, Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults, J Allergy Clin Immunol, 131, 1342, 10.1016/j.jaci.2013.03.019

Dahl, 2008, Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years, J Allergy Clin Immunol, 121, 512, 10.1016/j.jaci.2007.10.039

Li, 2015, Sublingual grass and ragweed immunotherapy: clinical considerations—a PRACTALL consensus report, J Allergy Clin Immunol

Hermelingmeier, 2012, Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta-analysis, Am J Rhinol Allergy, 26, e119, 10.2500/ajra.2012.26.3787

Cataldi, 2014, Histamine receptors and antihistamines: from discovery to clinical applications, Chem Immunol Allergy, 100, 214, 10.1159/000358740

Church, 2010, Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper, Allergy, 65, 459, 10.1111/j.1398-9995.2009.02325.x

Weiner, 1998, Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials, BMJ, 317, 1624, 10.1136/bmj.317.7173.1624

Pullerits, 1999, Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis, Am J Respir Crit Care Med, 159, 1814, 10.1164/ajrccm.159.6.9810016

Ratner, 2003, Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast, Ann Allergy Asthma Immunol, 90, 536, 10.1016/S1081-1206(10)61847-9

Jen, 2000, As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis, J Allergy Clin Immunol, 105, 732, 10.1067/mai.2000.105225

Dykewicz, 2003, Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn), Ann Allergy Asthma Immunol, 91, 44, 10.1016/S1081-1206(10)62057-1

Kaszuba, 2001, Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis, Arch Intern Med, 161, 2581, 10.1001/archinte.161.21.2581

Juniper, 1990, Aqueous beclomethasone diproprionate nasal spray: regular versus “as required” use in the treatment of seasonal allergic rhinitis, J Allergy Clin Immunol, 86, 380, 10.1016/S0091-6749(05)80101-0

Juniper, 1993, Aqueous beclomethasone dipropionate in the treatment of ragweed pollen-induced rhinitis: further exploration of “as needed” use, J Allergy Clin Immunol, 92, 66, 10.1016/0091-6749(93)90039-I

Lieberman, 2009, The role of antihistamines in the treatment of vasomotor rhinitis, World Allergy Organ J, 2, 156, 10.1097/WOX.0b013e3181b35322

Bernstein, 2007, Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability, Curr Med Res Opin, 23, 2441, 10.1185/030079907X226302

Taylor-Clark, 2005, Histamine receptors that influence blockage of the normal human nasal airway, Br J Pharmacol, 144, 867, 10.1038/sj.bjp.0706118

Cox, 1967, Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms, Nature, 216, 1328, 10.1038/2161328a0

Nayak, 2010, Tolerability of concomitant administration of mometasone furoate and oxymetazoline nasal sprays administered once daily vs oxymetazoline twice daily, mometasone furoate once daily, and placebo in the treatment of subjects with seasonal allergic rhinitis, J Allergy Clin Immunol, 125, Ab175, 10.1016/j.jaci.2009.12.685

Greiner, 2011, Allergic rhinitis, Lancet, 378, 2112, 10.1016/S0140-6736(11)60130-X

van Adelsberg, 2003, Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period, Allergy, 58, 1268, 10.1046/j.1398-9995.2003.00261.x

Wilson, 2004, Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis, Am J Med, 116, 338, 10.1016/j.amjmed.2003.10.030

Chen, 2006, Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr, Pediatr Allergy Immunol, 17, 49, 10.1111/j.1399-3038.2005.00351.x

Keskin, 2006, Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?, Pediatr Allergy Immunol, 17, 259, 10.1111/j.1399-3038.2006.00397.x

Martin, 2006, Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms, Ann Allergy Asthma Immunol, 96, 851, 10.1016/S1081-1206(10)61349-X

National Asthma, 2007, Expert Panel Report 3 (EPR-3): guidelines for the Diagnosis and Management of Asthma—Summary Report 2007, J Allergy Clin Immunol, 120, S94

Li, 1998, Ann Allergy Asthma Immunol, 81, 415, 10.1016/S1081-1206(10)63138-9

Chauhan, 2013, Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma, Cochrane Database Syst Rev, 10.1002/14651858.CD010347

Wood, 1995, Product characteristics and pharmacokinetics of intranasal ipratropium bromide, J Allergy Clin Immuno, 95, 1111, 10.1016/S0091-6749(95)70214-8

Tran, 2011, Management of rhinitis: allergic and non-allergic, Allergy Asthma Immunol Res, 3, 148, 10.4168/aair.2011.3.3.148

Meltzer, 2013, Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis, Am J Rhinol Allergy, 27, 102, 10.2500/ajra.2013.27.3864

Baroody, 2011, Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis, J Allergy Clin Immunol, 127, 927, 10.1016/j.jaci.2011.01.037

Vaidyanathan, 2010, Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion, Am J Respir Crit Care Med, 182, 19, 10.1164/rccm.200911-1701OC

Graf, 1995, The pathophysiology and treatment of rhinitis medicamentosa, Clin Otolaryngol Allied Sci, 20, 224, 10.1111/j.1365-2273.1995.tb01853.x

Petty, 2013, Intranasal corticosteroids topical characteristics: side effects, formulation, and volume, Am J Rhinol Allergy, 27, 510, 10.2500/ajra.2013.27.3949

Epstein, 2011, Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy: year 2, Ann Allergy Asthma Immunol, 107, 426, 10.1016/j.anai.2011.05.020

Zhang, 2013, The clinical use of cetirizine in the treatment of allergic rhinitis, Pharmacology, 92, 14, 10.1159/000351843

Yuen, 2013, Effect of beclomethasone nasal spray on intraocular pressure in ocular hypertension or controlled glaucoma, J Glaucoma, 22, 84, 10.1097/IJG.0b013e3182254811

Schenkel, 2000, Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray, Pediatrics, 105, E22, 10.1542/peds.105.2.e22

Bernstein, 2009, Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitis, Am J Rhinol Allergy, 23, 512, 10.2500/ajra.2009.23.3396

Cross, 2016, Potentially inappropriate medications and anticholinergic burden in older people attending memory clinics in Australia, Drugs Aging, 33, 37, 10.1007/s40266-015-0332-3

Collamati, 2015, Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence, Aging Clin Exp Res

Hanlon, 2015, Alternative medications for medications in the use of high-risk medications in the elderly and potentially harmful drug-disease interactions in the elderly quality measures, J Am Geriatr Soc, 63, e8, 10.1111/jgs.13807

Gray, 2015, Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study, JAMA Intern Med, 175, 401, 10.1001/jamainternmed.2014.7663

Braido, 2014, New therapies for allergic rhinitis, Curr Allergy Asthma Rep, 14, 422, 10.1007/s11882-014-0422-z

Wambre, 2014, Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner, J Allergy Clin Immunol, 133, 872, 10.1016/j.jaci.2013.10.054